Mariner
INO icon

Mariner’s Inovio Pharmaceuticals INO Stock Holding History

Mariner’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-12,856
Closed -$21K – 3573
2025
Q1 		$21K Buy
+12,856
New +$25.8K ﹤0.01% 3375
2024
Q1 		– Sell
-6,429
Closed -$39.3K – 3187
2023
Q4 		$39.3K Buy
6,429
+88
+1% +$434 ﹤0.01% 2958
2023
Q3 		$29.6K Buy
6,341
+5,226
+469% +$28.9K ﹤0.01% 2819
2023
Q2 		$6.05K Buy
1,115
+8
+0.7% +$64 ﹤0.01% 2819
2023
Q1 		$11K Sell
1,107
-552
-33% -$9.41K ﹤0.01% 2755
2022
Q4 		$31K Buy
1,659
+394
+31% +$8.93K ﹤0.01% 2657
2022
Q3 		$26K Buy
+1,265
New +$32.4K ﹤0.01% 2369

Other funds holding INO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Mariner's INO Position: Q2 2025 in Review

Mariner sold out of Inovio Pharmaceuticals (INO) in Q2 2025, closing a stake of 12,856 shares — an estimated $21K sold.

Mariner first reported a position in INO in Q3 2022 and held it in 7 quarters. The position peaked at $39.3K in Q4 2023. 103 funds tracked by Wall St. Rank hold INO as of Q2 2025.

  • Mariner reported no remaining Inovio Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Mariner sold 12,856 Inovio Pharmaceuticals shares in Q2 2025, an estimated $21K.
  • Mariner first reported a position in Inovio Pharmaceuticals in Q3 2022 and held it in 7 quarters.
  • Mariner's Inovio Pharmaceuticals position peaked at $39.3K in Q4 2023.
  • 103 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2025.

Based on Mariner's 13F filing for Q2 2025, filed 14 Aug 2025.